期刊文献+

5'-氮杂-2'-脱氧胞苷对HT-29和LoVo结直肠癌细胞株中Wif-1基因甲基化状态、mRNA表达及蛋白表达的影响 被引量:1

Effect of 5-Aza-dC on mRNA expression, protein expression and methylation of Wif-1 gene status in HT-29 and LoVo Colorectal cancer
下载PDF
导出
摘要 目的探讨甲基化酶抑制剂5'-氮杂-2'-脱氧胞苷(5'-Aza-2'-deoxycytidine,5'-Aza-CdR)对结直肠癌细胞株HT-29和LoVo中Wif-1基因甲基化水平及蛋白表达的影响。方法用不同浓度(0.5、1.0、1.5μmol/L)5'-Aza-CdR处理结直肠癌细胞株HT-29和LoVo。应用TaqMan探针为基础的实时定量PCR(Methylight)方法、SYBR Green PCR方法及蛋白印迹实验(Western blot)检测药物处理前后HT-29和LoVo细胞中Wif-1基因的甲基化状态、mRNA和蛋白表达。结果 Methylight检测HT-29和LoVo细胞中Wif-1蛋白在药物作用后异常甲基化得到逆转;实时荧光定量PCR和Western Blot检测到0.5、1.0、1.5μmol/L 5'-Aza-CdR处理后Wif-1基因mRNA和蛋白重新表达,实时荧光定量PCR检测DMSO对照组和不同浓度5'-Aza-CdR(0.5、1.0、1.5μmol/L)在HT-29细胞株相对表达量分别为(1.000±0.000)、(1.207±0.052)、(1.790±0.033)和(2.016±0.123);在LoVo细胞株相对表达量分别为(1.000±0.000)、(1.294±0.048)、(1.893±0.061)和(2.204±0.041)。Western blot检测Wif-1蛋白检测DMSO对照组和不同浓度5'-Aza-CdR在HT-29细胞株相对表达量分别为(0.456±0.040)、(0.511±0.025)、(0.857±0.031)和(0.934±0.047);LoVo细胞株相对表达量分别为(0.842±0.032)、(0.844±0.044)、(0.854±0.037)和(0.856±0.034)。以上作用均呈时间、剂量依赖性,Wif-1基因mRNA在HT-29细胞株表达和LoVo细胞株表达差异均有高度统计学意义(F=144.823,P=0.000;F=476.195,P=0.000)。Wif-1蛋白表达在HT-29细胞株表达差异有高度统计学意义(F=129.674,P=0.000),但Wif-1蛋白表达在LoVo细胞株表达差异无统计学意义(F=0.117,P=0.948)。结论结直肠癌细胞株HT-29和LoVo中Wif-1启动子甲基化可能是导致该基因表达下调甚至失活的主要原因。5'-Aza-CdR能够较成功地逆转结直肠癌细胞株HT-29和LoVo中Wif-1基因的甲基化状态,并能恢复mRNA及蛋白重新表达。 Objective To investigate the effects of 5-Aza-2-deoxycytidine (5-Aza-dC), a methylation inhibitor, on the mRNA expression, protein expression of W if-1 gene in HT-29 and LoVo Colorectal cancer cell lines. Methods HT-29 and LoVo Colorectal cancer cell lines was treated with different dosages of 5-Aza-dC. W if-1 gene DNA, mRNA and protein were determined by Methylight, SYBR Green PCR and Western blot respectively. HT-29 and LoVo Colorectal cancer cell lines were treated with different dosages of 5-Aza-dC (0.5, 1.0, 1.5μmol/L). W if-1 gene DNA, mRNA and protein were determined by Methylight, SYBR Green PCR and Western blot respectively. Results Methylight detection showed that the W if-1 gene methylation had effectively been reverserd by 5-Aza-dC. Moreover, the expression levels of W if-1 gene mRNA treated with 5-Aza-dC increased respectively in HT-29 Colorectal cell line [(1.000±0.000), (1.207±0.052), (1.790±0.033), (2.016±0.123)], and the expression levels of W if-1 gene mRNA treated with 5-Aza-Dc increased respectively in LoVo Colorectal cell line [(1.000±0.000), (1.294±0.048), (1.893±0.061), (2.204±0.041)]. West-ern blot indicated that 5-Aza-dC could recover the Wif-1 protein expression respectively in HT-29 Colorectal cell line [(0.456±0.040), (0.511±0.025), (0.857±0.031), (0.934±0.047)], and the protein expression was (0.842±0.032), (0.844±0.044), (0.854±0.037), (0.856±0.034), respectively in LoVo Colorectal cell line. The W if-1 gene mRNA effects within certain extent dose and time dependent with statistical significance in HT-29 Colorectal cancer line (F=144.823, P=0.000) and LoVo Colorectal cancer line (F=476.195, P=0.000), and the Wif-1 protein effects within certain extent dose and time dependent with statistical significance in HT-29 Colorectal cancer line (F=129.674, P=0.000), but without statistical significance in LoVo Colorectal cancer line (F=0.117, P=0.948). Conclusion The methylation of pro-moter region is a main cause for transcriptional inactivation of W if-1 gene in HT-29 and LoVo Colorectal cancer cell lines. 5-Aza-dC may effectively reactivate the gene transcription through a demethylation role.
出处 《中国医药导报》 CAS 2014年第23期16-21,共6页 China Medical Herald
基金 首都卫生发展科研专项基金课题(编号2011-5021-02)
关键词 DNA甲基化 5’-Aza-CdR HT-29 LOVO WIF-1基因 DNA methylation 5-Aza-dC HT-29 LoVo Wif-1 gene
  • 相关文献

参考文献17

  • 1Siegel R,Ma J,Zou Z,et al. Cancer statistics [J]. CA Can- cer J Clin,2014,64(1):9-29.
  • 2Karim R, Tse G, Putti T, et al. The significance of the Wnt pathway in the pathology of human cancers [J]. Pathology, 2004,36(2) : 120-128.
  • 3Ogino S, Kawasaki T,Brahmandam M ,et al. Precision and performance characteristics of bisulfite conversion and re- al-time PCR(MethyLight) for quantitative DNA methyla- tion analysis [J]. J Mol Diagn,2006,8(2):209-217.
  • 4Campbell D J, Koch MA. Phenotypical and functional spe- cialization of FOXP3+ regulatory T cells [J]. Nat Rev Im- munol,2011,11 (2) : 119-130.
  • 5Snover DC. Update on the serrated pathway to colorectal carcinoma [J]. Hum Pathol, 2011,42( 1 ) : 1-10.
  • 6Dhir M,Yachida S,Van Neste L,et al. Sessile serrated ade- nomas and classical adenomas :an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract [J]. Int J Cancer,2011,129(8) :1889-1898.
  • 7Arber N,Shapira I ,Ratan J ,et al. Activation of c-K-ras mu- tations in human gastrointestinal tumors [J]. Gastroenterol- ogy,2000,118(6) :1045-1050.
  • 8Hsieh JC,Kodjabachian L,Rebbert ML,et al. A new se- creted protein that binds to Wnt proteins and inhibits their activities [J]. Nature, 1999,398 (6726) : 431-436.
  • 9Nosho K,Yamamoto H,Takahashi T,et al. Genetic and epi- genetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal can- cers [J]. Carcinogenesis,2007,28(6) :1364-1370.
  • 10Chan SL,Cui Y,van Hasselt A,et al. The tumor sup- pressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas [J]. Lab In- vest, 2007,87 (7) : 644-650.

二级参考文献12

  • 1方晓明,孙立峰,彭佳萍,董琦,郑树.5-氮-2′-脱氧胞苷对RKO结肠癌细胞株p16/CDKN2基因去甲基化的转录调节作用[J].中华医学杂志,2003,83(23):2077-2082. 被引量:13
  • 2张辉,王杉,张有成,叶颖江,崔志荣,方伟岗.信号传导子和激活子3通路与结直肠癌中环氧化酶2表达的相关性研究[J].中华医学杂志,2005,85(41):2899-2904. 被引量:5
  • 3Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci, 2003, 116: 2627-2634.
  • 4Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet, 2004, 36:417-422.
  • 5Lee AY, He B, You L, et al. Expression of the secreted frizzled- related protein gene family is downregulated in human mesothelioma. Oncogene, 2004, 23:6672-6676.
  • 6Zou H, Molina JR, Harrington JJ, et al. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer, 2005, 116:584-591.
  • 7Wissmann C, Wild PJ, Kaiser S, et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol, 2003, 201:204-212.
  • 8Esteller M, Corn PG, Baylin SB, et al. A gene hypermethylation profile of human cancer. Cancer Res, 2001, 61:3225-3229.
  • 9Chan AO, Broaddus RR, Houlihan PS, et al. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol, 2002, 160:1823-1830.
  • 10Herman JG, Graft JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996, 93:9821-9826.

共引文献5

同被引文献37

  • 1张松,孔维佳,王彦君,韩月臣,张丹.5-杂氮-2′-脱氧胞苷对人鼻咽癌裸鼠移植瘤的抑制作用[J].癌症,2005,24(10):1201-1205. 被引量:15
  • 2赵润年,刘晓勇,张亚锋.5-氮-2-脱氧胞苷的研究进展[J].实用医技杂志,2006,13(4):554-556. 被引量:1
  • 3曾恒,陈安民,李锋,方煌,夏仁云.骨肉瘤诱导分化与多药耐药表型的生物学性状比较[J].中国矫形外科杂志,2007,15(13):1019-1022. 被引量:3
  • 4Broadhead ML,Clark JC,Myers DE,et al.The molecular pathogenesis of osteosarcoma: a review.Sarcoma.2011;2011:959248.
  • 5Kawano Y,Kypta R.Secreted antagonists of the Wnt signalling pathway.J Cell Sci.2003;116(Pt 13):2627-2634.
  • 6Chuang JC,Warner SL,Vollmer D,et al.S110,a 5-Aza-2'-deoxycytidine-containing dinucleotide,is an effective DNA methylation inhibitor in vivo and can reduce tumor growth.Mol Cancer Ther.2010;9(5):1443-1450.
  • 7Rubin EM,Guo Y,Tu K,et al.Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.Mol Cancer Ther.2010:9(3):731-741.
  • 8Blattmann C,Thiemann M,Stenzinger A,et at.Establishment of a patient-derived orthotopic osteosarcoma mouse model.J Transl Med.2015:13:136.
  • 9Schmidt J,Strauss GP,Schon A,et al.Establishment and characterization of osteogenic cell lines from a spontaneous murine osteosarcoma.Differentiation.1988:39(3):151-160.
  • 10Matsuzaki K,Katayama K,Takahashi Y,et al.Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene.Endocrinology.1999;140(2):925-932.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部